Despite reports of errors using the da Vinci system, Intuitive Surgical has put up good numbers so far. Total procedures rose 25% in the fourth quarter and 29% in last year's first quarter. The company sold 175 and 140 da Vinci systems, respectively, during those periods.
For its part, Wall Street is expecting revenue to grow 17.7% to $582.9 million, resulting in $3.99 of profit per share. The company has beat earnings estimates in each of the past four quarters, according to data supplied by Yahoo! Finance. Intuitive Surgical stock is still down nearly 6% over that period.
Would another beat send Intuitive Surgical stock soaring? Tim Beyers of Motley Fool Rule Breakers and Motley Fool Supernova weighs in on this question in the video below. Please watch and then leave a comment to let us know what you whether you would buy, sell, or short Intuitive Surgical stock at current prices.
Are stories of this demise greatly exaggerated?
Recently, some investors have questioned Intuitive Surgical's future. However, Intuitive Surgical expert Karl Thiel believes a visible path to long-term growth persists. Will Intuitive capitalize, or be crushed by unforeseen pitfalls? His report highlights all of the key opportunities and risks facing the company -- and includes a full year of ongoing updates as key new hits -- so be sure to claim your copy by clicking here now.